Antipsychotic efficacy of clozapine in correlation to changes in catecholamine metabolism in man.
D001714:Bipolar Disorder / Q000097:blood / Q000134:cerebrospinal fluid / Q000188:drug therapy / Q000652:urine; D002250:Carbon Radioisotopes; D002395:Catecholamines / Q000378:metabolism*; D002849:Chromatography, Gas; D003984:Dibenzazepines / Q000097:blood / Q000494:pharmacology / Q000627:therapeutic use*; D004299:Dopamine beta-Hydroxylase / Q000097:blood; D006719:Homovanillic Acid / Q000134:cerebrospinal fluid / Q000652:urine; D006801:Humans; D006897:Hydroxyindoleacetic Acid / Q000134:cerebrospinal fluid / Q000652:urine; D008297:Male; D008734:Methoxyhydroxyphenylglycol / Q000134:cerebrospinal fluid / Q000652:urine; D010879:Piperazines / Q000097:blood / Q000494:pharmacology / Q000627:therapeutic use; D011569:Psychiatric Status Rating Scales; D012559:Schizophrenia / Q000097:blood / Q000134:cerebrospinal fluid / Q000188:drug therapy / Q000652:urine; D013997:Time Factors; D014149:Tranquilizing Agents / Q000097:blood / Q000494:pharmacology / Q000627:therapeutic use*
D002250:Carbon Radioisotopes; D002395:Catecholamines; D003984:Dibenzazepines; D010879:Piperazines; D014149:Tranquilizing Agents; D008734:Methoxyhydroxyphenylglycol; D006897:Hydroxyindoleacetic Acid; D004299:Dopamine beta-Hydroxylase; D006719:Homovanillic Acid